Endocrine Disrupting Chemicals (EDCs) and Female Cancer: Informing the Patients

Overview

Journal Rev Endocr Metab Disord

Publisher Springer

Specialty Endocrinology

Date 2016 Feb 3

PMID 26831296

Citations 30

Authors

Dominik Rachon

Affiliations

Soon will be listed here.

Abstract

Breast and uterine cancer are the most frequent female gender related neoplasms whose growth is mostly estrogen dependent. Therefore, any EDC exhibiting estrogenic effects may increase the risk of these two malignancies. This review focuses on the potential role of EDCs with estrogenic potential on the risk of breast and uterine neoplasms but also points to the possible role of the exposure to EDCs in the pathogenesis of ovarian and cervical cancer. It also underlines the necessity of informing the public about the presence of EDCs in common consumer products, their detrimental health effects and methods of reducing the exposure risk.

Citing Articles

Preclinical research models for endometrial cancer: development and selection of animal models.

Xue Y, Shi W, Lun B, Kan M, Jia M, Wu Y Front Oncol. 2025; 15:1512616.

PMID: 39975595 PMC: 11835666. DOI: 10.3389/fonc.2025.1512616.

Unlocking India's Potential in Managing Endocrine-Disrupting Chemicals (EDCs): Importance, Challenges, and Opportunities.

Sharma B, Scheringer M, Chakraborty P, Bharat G, Steindal E, Trasande L Expo Health. 2022; :1-15.

PMID: 36530567 PMC: 9744066. DOI: 10.1007/s12403-022-00519-8.

Exposure to Microplastics during Early Developmental Stage: Review of Current Evidence.

Amran N, Zaid S, Mokhtar M, Manaf L, Othman S Toxics. 2022; 10(10).

PMID: 36287877 PMC: 9611505. DOI: 10.3390/toxics10100597.

Environmental Distribution of Personal Care Products and Their Effects on Human Health.

Khalid M, Abdollahi M Iran J Pharm Res. 2021; 20(1):216-253.

PMID: 34400954 PMC: 8170769. DOI: 10.22037/ijpr.2021.114891.15088.

The Adipose Tissue at the Crosstalk Between EDCs and Cancer Development.

Bokobza E, Hinault C, Tiroille V, Clavel S, Bost F, Chevalier N Front Endocrinol (Lausanne). 2021; 12:691658.

PMID: 34354670 PMC: 8329539. DOI: 10.3389/fendo.2021.691658.

References

Rachon D, Vortherms T, Seidlova-Wuttke D, Menche A, Wuttke W . Uterotropic effects of dietary equol administration in ovariectomized Sprague-Dawley rats. Climacteric. 2007; 10(5):416-26. DOI: 10.1080/13697130701624757. View

Soto A, Sonnenschein C . The tissue organization field theory of cancer: a testable replacement for the somatic mutation theory. Bioessays. 2011; 33(5):332-40. PMC: 3933226. DOI: 10.1002/bies.201100025. View

Diamanti-Kandarakis E, Palioura E, Kandarakis S, Koutsilieris M . The impact of endocrine disruptors on endocrine targets. Horm Metab Res. 2010; 42(8):543-52. DOI: 10.1055/s-0030-1252034. View

Albini A, Rosano C, Angelini G, Amaro A, Esposito A, Maramotti S . Exogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptors. Curr Med Chem. 2013; 21(9):1129-45. PMC: 4153070. View

Liu R, Nelson D, Hurley S, Hertz A, Reynolds P . Residential exposure to estrogen disrupting hazardous air pollutants and breast cancer risk: the California Teachers Study. Epidemiology. 2015; 26(3):365-73. PMC: 5101045. DOI: 10.1097/EDE.0000000000000277. View

Cohn B, La Merrill M, Krigbaum N, Yeh G, Park J, Zimmermann L . DDT Exposure in Utero and Breast Cancer. J Clin Endocrinol Metab. 2015; 100(8):2865-72. PMC: 4524999. DOI: 10.1210/jc.2015-1841. View

Aschengrau A, Coogan P, Quinn M, Cashins L . Occupational exposure to estrogenic chemicals and the occurrence of breast cancer: an exploratory analysis. Am J Ind Med. 1998; 34(1):6-14. DOI: 10.1002/(sici)1097-0274(199807)34:1<6::aid-ajim2>3.0.co;2-x. View

Konieczna A, Rutkowska A, Rachon D . Health risk of exposure to Bisphenol A (BPA). Rocz Panstw Zakl Hig. 2015; 66(1):5-11. View

Vandenberg L, Hauser R, Marcus M, Olea N, Welshons W . Human exposure to bisphenol A (BPA). Reprod Toxicol. 2007; 24(2):139-77. DOI: 10.1016/j.reprotox.2007.07.010. View

10.

Rochester J . Bisphenol A and human health: a review of the literature. Reprod Toxicol. 2013; 42:132-55. DOI: 10.1016/j.reprotox.2013.08.008. View

11.

BARCLAY D . Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies). J Ark Med Soc. 1979; 75(12):451-2. View

12.

Sternlicht M, Kouros-Mehr H, Lu P, Werb Z . Hormonal and local control of mammary branching morphogenesis. Differentiation. 2006; 74(7):365-81. PMC: 2580831. DOI: 10.1111/j.1432-0436.2006.00105.x. View

13.

Arrebola J, Belhassen H, Artacho-Cordon F, Ghali R, Ghorbel H, Boussen H . Risk of female breast cancer and serum concentrations of organochlorine pesticides and polychlorinated biphenyls: a case-control study in Tunisia. Sci Total Environ. 2015; 520:106-13. DOI: 10.1016/j.scitotenv.2015.03.045. View

14.

Reaves D, Ginsburg E, Bang J, Fleming J . Persistent organic pollutants and obesity: are they potential mechanisms for breast cancer promotion?. Endocr Relat Cancer. 2015; 22(2):R69-86. PMC: 4352112. DOI: 10.1530/ERC-14-0411. View

15.

Lee H, Chattopadhyay S, Gong E, Ahn R, Lee K . Antiandrogenic effects of bisphenol A and nonylphenol on the function of androgen receptor. Toxicol Sci. 2003; 75(1):40-6. DOI: 10.1093/toxsci/kfg150. View

16.

Cooper R, Hardy R, Kuh D . Is adiposity across life associated with subsequent hysterectomy risk? Findings from the 1946 British birth cohort study. BJOG. 2007; 115(2):184-92. DOI: 10.1111/j.1471-0528.2007.01569.x. View

17.

Hiroi H, Tsutsumi O, Takeuchi T, Momoeda M, Ikezuki Y, Okamura A . Differences in serum bisphenol a concentrations in premenopausal normal women and women with endometrial hyperplasia. Endocr J. 2005; 51(6):595-600. DOI: 10.1507/endocrj.51.595. View

18.

Brieno-Enriquez M, Reig-Viader R, Cabero L, Toran N, Martinez F, Roig I . Gene expression is altered after bisphenol A exposure in human fetal oocytes in vitro. Mol Hum Reprod. 2011; 18(4):171-83. DOI: 10.1093/molehr/gar074. View

19.

Lee H, Ormandy C . Interplay between progesterone and prolactin in mammary development and implications for breast cancer. Mol Cell Endocrinol. 2011; 357(1-2):101-7. DOI: 10.1016/j.mce.2011.09.020. View

20.

Halldorsson T, Rytter D, Haug L, Bech B, Danielsen I, Becher G . Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study. Environ Health Perspect. 2012; 120(5):668-73. PMC: 3346773. DOI: 10.1289/ehp.1104034. View